tenofovir has been researched along with gold in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 2 (66.67) | 2.80 |
| Authors | Studies |
|---|---|
| Arami, H; Cai, Y; Febo, M; Huang, Z; Nair, M; Raymond, A; Rodriguez, E; Takemura, Y; Tomitaka, A | 1 |
| Bacchetti, P; Baeten, JM; Cressey, TR; Drain, PK; Gandhi, M; Glidden, DV; King, R; Klinbuayaem, V; Mugo, NR; Ngure, K; Okochi, H; Rodrigues, WC; Siriprakaisil, O; Spinelli, MA; Vincent, M; Wang, G | 1 |
| Fotooh Abadi, L; Gajbhiye, V; Kulkarni, S; Kumar, P; Paknikar, K | 1 |
3 other study(ies) available for tenofovir and gold
| Article | Year |
|---|---|
Hybrid magneto-plasmonic liposomes for multimodal image-guided and brain-targeted HIV treatment.
Topics: Anti-Retroviral Agents; Blood-Brain Barrier; Brain; Cell Line; Drug Delivery Systems; Gold; HIV Infections; Humans; Liposomes; Magnetics; Metal Nanoparticles; Microglia; Multimodal Imaging; Nanomedicine; Tenofovir | 2017 |
Development and validation of the first point-of-care assay to objectively monitor adherence to HIV treatment and prevention in real-time in routine settings.
Topics: Anti-HIV Agents; Chromatography, Liquid; Gold; HIV Infections; Humans; Medication Adherence; Metal Nanoparticles; Point-of-Care Testing; Pre-Exposure Prophylaxis; Tandem Mass Spectrometry; Tenofovir | 2020 |
Tenofovir-tethered gold nanoparticles as a novel multifunctional long-acting anti-HIV therapy to overcome deficient drug delivery-: an in vivo proof of concept.
Topics: Acquired Immunodeficiency Syndrome; Anti-HIV Agents; Gold; HIV Infections; Humans; Metal Nanoparticles; Peptide Hydrolases; Tenofovir; Tissue Distribution | 2023 |